Effect of glucagon-like peptide-1 on major cardiovascular outcomes in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. [electronic resource]
- International journal of cardiology Nov 2016
- 957-962 p. digital
Cardiovascular Diseases--drug therapy Diabetes Mellitus, Type 2--complications Global Health Glucagon-Like Peptide 1--therapeutic use Humans Incretins--therapeutic use Randomized Controlled Trials as Topic Reproducibility of Results Survival Rate--trends